Smith & Nephew (SNN)
| Bid | 27.98 |
| Market Cap | 12.41B |
| Revenue (ttm) | 2.82B |
| Net Income (ttm) | 152.51M |
| EPS (ttm) | 0.94 |
| PE Ratio (ttm) | 30.22 |
| Forward PE | 15.57 |
| Analyst | Hold |
| Ask | 30.66 |
| Volume | 847,583 |
| Avg. Volume (20D) | 873,024.7 |
| Open | 28.44 |
| Previous Close | 28.43 |
| Day's Range | 28.34 - 28.70 |
| 52-Week Range | 23.65 - 31.72 |
| Beta | 0.72 |
About SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint re...
Analyst Forecast
According to 2 analyst ratings, the average rating for SNN stock is "Hold." The 12-month stock price forecast is $27, which is a decrease of -4.96% from the latest price.
Stock Forecasts
1 month ago · proactiveinvestors.co.uk
Smith & Nephew sees turnaround plan kicking in as profit growsSmith & Nephew PLC has said 2025 should show its transformation plan kicking in despite ongoing woes in China after improving trading over the last year. Revenue climbed 4.7% to US$5.8 billion in the ...
1 month ago · proactiveinvestors.co.uk
Smith & Nephew has to impress in results after ringing warning bellSmith & Nephew PLC has left itself with the mounting task of having to give investors something to cheer about after ringing the warning bell last time out. Ahead of full-year figures on Tuesday, 25 F...
